The shares were purchased at the public offering price of $15 per share.
EndoChoice is expected to realize $94.9 million in proceeds from the offering, including the proceeds from the option exercise.
EndoChoice’s stock is trading on the New York Stock Exchange under the symbol “GI.”
More articles on gastroenterology:
Consumerism is taking healthcare by storm: How is GI affected?
EndoChoice IPO update: Common stock price set at $15 per share
Frisbie Memorial Hospital begins to offer virtual colonoscopy
